Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[Pathomechanisms of autoantibody production against the nervous system].

Arimura K.

Brain Nerve. 2013 Apr;65(4):323-32. Review. Japanese.

PMID:
23568980
2.

The thymus in myasthenia gravis: Site of "innate autoimmunity"?

Cavalcante P, Le Panse R, Berrih-Aknin S, Maggi L, Antozzi C, Baggi F, Bernasconi P, Mantegazza R.

Muscle Nerve. 2011 Oct;44(4):467-84. doi: 10.1002/mus.22103.

PMID:
21922466
3.
4.

[Pathomechanism of autoantibody production in neurological disorders].

Watanabe O, Arimura K.

Nihon Rinsho. 2008 Jun;66(6):1065-72. Review. Japanese.

PMID:
18540349
5.

Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.

Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.

J Neuroimmunol. 2006 Aug;177(1-2):201-8. Epub 2006 Jul 14.

PMID:
16844234
6.

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.

Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K.

J Neuroimmunol. 1998 Jan;81(1-2):116-26.

PMID:
9521613
8.

Neuroimmunology I: Immunoregulation in neurological disease.

Weiner HL, Hauser SL.

Ann Neurol. 1982 May;11(5):437-49.

PMID:
6179458
9.

Anti-ganglioside antibody and neuropathy: review of our research.

Yuki N.

J Peripher Nerv Syst. 1998;3(1):3-18. Review.

PMID:
10959233
10.

Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.

Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR.

Ann N Y Acad Sci. 1987;505:526-38.

PMID:
3479935
11.

Ganglioside mimicry as a cause of Guillain-Barré syndrome.

Komagamine T, Yuki N.

CNS Neurol Disord Drug Targets. 2006 Aug;5(4):391-400. Review.

PMID:
16918391
12.

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.

Koga M, Takahashi M, Masuda M, Hirata K, Yuki N.

Neurology. 2005 Nov 8;65(9):1376-81. Epub 2005 Sep 14.

PMID:
16162859
13.

Myasthenia gravis.

Marx A, Schultz A, Wilisch A, Nenninger R, Müller-Hermelink HK.

Verh Dtsch Ges Pathol. 1996;80:116-26. Review.

PMID:
9020569
14.

Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.

Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.

J Neurol Sci. 2006 Jul 15;246(1-2):163-8.

PMID:
16600306
15.

B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.

Dalakas MC.

Pharmacol Ther. 2006 Oct;112(1):57-70. Epub 2006 Apr 27. Review.

PMID:
16644016
16.

Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.

Shiono H, Wong YL, Matthews I, Liu JL, Zhang W, Sims G, Meager A, Beeson D, Vincent A, Willcox N.

Int Immunol. 2003 Aug;15(8):903-13.

PMID:
12882828
17.

[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].

Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.

Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97. French.

18.
19.

No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.

Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E, Autelli M, Masanti ML, Cuccia M, Tinelli C, Rondini G, Lorini R.

Pediatrics. 2002 Jul;110(1 Pt 1):e4.

PMID:
12093985
20.

Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.

Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV.

Neurology. 1986 May;36(5):618-21.

PMID:
3486379

Supplemental Content

Support Center